-
Daliresp
Roflumilast reduces inflammation in the lungs that leads to COPD (chronic obstructive pulmonary disease). Roflumilast is used to prevent worsening of symptoms in people with severe COPD. Roflumilast is not a bronchodilator and will not treat a bronchospasm attack that has already begun.